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Abstract
  
 Carbonated hydroxyapatite is frequently used as bone graft material in dentistry. It 
is highly biocompatible, has osteoconductive properties and functions as a drug delivery 
system. Propolis is a natural product from bees that has antibacterial and anti-inflammatory 
effects and is capable of accelerating wound healing. Incorporating propolis into carbonated 
hydroxyapatite was expected to enhance the wound-healing process and regenerating alveolar 
bone in the treatment of periodontitis by stimulating fibroblast growth. The aim of this study 
was to obtain the best concentration of propolis which was incorporated into the carbonated 
hydroxyapatite bone graft material to increasing the growth of 3T3 fibroblast cells. This study 
used three treatment groups [carbonated hydroxyapatite with various concentrations of 
incorporated propolis (5%, 7.5% and 10%)] and one control group (carbonated hydroxyapatite 
with no propolis). An 3-(4,5-dimetilazol-2-il)-2,5-difeniltetrazolium bromida (MTT) assay 
was carried out to assess cell viability and absorbance readings were performed by using an 
ELISA reader. The data were analyzed by using one-way ANOVA. The results showed significant 
differences between all groups and carbonated hydroxyapatite with 10% incorporated propolis 
has the highest cell growth level (125.14%) of all groups, while the control group has the lowest 
cell growth. In conclusion, adding propolis to carbonated hydroxyapatite could increase the 
growth of NIH 3T3 fibroblast cells.
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INTRODUCTION
 Periodontitis is one  the  most  common 
diseases in dentistry. This chronic inflammatory 
disease is caused by anaerobic bacteria and could 
lead  to  the  loss  of  clinical  attachment  from 
periodontal ligament and alveolar bone. Periodontal 
ligament is a connective tissue that covers the tooth 
root and connects the cementum at the root of the 
tooth with alveolar bone. In addition to the fibers in 
the periodontal ligament, there are also fibroblast 
cells, endothelial cells, among others cementoblasts 
and osteoclasts (Carranzza, et al., 2012). Distur-
bance of fibroblast cells decreases collagen synthe-
sis, which is manifest as various diseases, such as 
periodontal disease (Fives-Taylor, et al., 1996). 
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 Alveolar bone loss is one of the outcomes 
of periodontitis. Bone grafting is a remodeling 
therapy that can be used to treat alveolar bone loss. 
Carbonated  hydroxyapatite is a biocompatible 
alloplastic  graft  or  synthetic bone graft and is used 
for the management of localized bone loss (Suku-
mar and Drizhal, 2008) that has osteoconductive 
property and can also function as drug delivery sys-
tems (Ding, et al., 2012). The chemical formula of 
carbonated hydroxyapatite is Ca10(PO4CO3)6(OH)2. 
The -OH groups in hydroxyapatite can act as active 
sites to adsorb bioactive molecules by hydrogen 
bonds, and thus improve the drug loading and re-
lease properties (Guo, et al., 2012).
 Wound healing is a complex and ongoing 
physiological process. Tissue repair begins after the 
injury in 3 phases: inflammation, proliferation, and 
remodeling, involving various cells such as keratino-
cytes, fibroblasts, and endothelial cells. The most 
important cells among these are  fibroblasts,   respon-
sible   for    initiating    angiogenesis,   epithelializa-
tion  and  collagen  formation (Jacob, et al., 2015).
 There has  been  increased   interest  in 
recent   evidence-based complementary and alter-
native medicine research using natural products 
for wound healing (Jacob, et al., 2015). Propo-
lis is a natural resin produced by bees from plant 
exudate and tree buds and mixed with bees wax 
and enzymes.  Propolis has several  therapeutic 
effects, such  as  anti-inflammatory,  immuno-
modulatory, antioxidant, antibacterial (Aral, et al., 
2015), and osteoinduction (Abdellatif, et al., 2014). 
Propolis    contains    flavonoids    that  work   to 
stimulate  the  production  of  growth  factors  and 
works  by   increasing  the  production of  growth 
factors,  in  particular, transforming growth fac-
tor β (TGF-β)  and vascular   endothelial   growth 
factor,  which   stimulate  fibroblast  proliferation 
and blood vessel formation (Suryono, et al., 2017).
MATERIALS AND METHODS
Preparation of Carbonated Hydroxyapatite
 Carbonated hydroxyapatite (Gama-Cha®) 
used in this study was manufactured by PT. Swayasa 
Prakarsa, Yogyakarta, Indonesia. This carbonated 
hydroxyapatite is cylindrical with a length of 10 
mm, a diameter of 6 mm, and a weight of 70 mg. 
The samples were cut and weighed to 10 mg each.
Preparation of Propolis Solution.
 Propolis was diluted by double distilled 
water gradually to obtain concentrations of 10%, 
7.5%, and 5%. The propolis used in this study was 
Propolis Brazilian® produced in Minas Gerais and 
distributed by Nusa Mega. 
Figure 1. Propolis solution and slice of carbonated 
hydroxyapatite.
Preparation of Carbonated Hydroxyapatite 
with Incorporated Propolis
 The carbonated hydroxyapatite were cut 
and weighed to 10 mg each and propolis was di-
luted by double distilled water to get various con-
centrations at 5%, 7.5%, and 10%.  Carbonated 
hydroxyapatite was embedded  in 1.5 mL  propo-
lis at  various  concentrations  for  24 h  at room 
temperature. After embedding, the propolis solu-
tion was separated from carbonated hydroxyapatite 
by using a micropipette. The incorporated samples 
were then covered with filter paper and placed in 
an incubator at 37°C for 24 h to dry out and then 
the samples were sterilized by using ethylene oxide 
(Grenho, et al., 2005).
Cell Culture Preparation
 Fibroblast  cells were acquired from the 
Parasitology Laboratory, Faculty of  Medicine, 
Public Health, and Nursing (FKKMK), Universitas 
Gadjah Mada. To access the material cytocompati-
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bility, carbonated hydroxyapatite impregnated with 
5%, 7.5%, and 10% propolis was selected as the test 
material. Non-treated carbonated hydroxyapatite 
was used as a control. In this study fibroblast cell 
line was used from ATCC with the number NIH3T3. 
The cell lines were seeded on material samples at 
a density of 1x104 cells/mL in Dulbecco’s  modi-
fied Eagle’s medium (DMEM) (Sigma-Aldrich, 
St. Louis, Missouri, USA) supplemented with 
10% Fetal bovine serum (FBS) (Sigma-Aldrich), 
100 IU/mL penicillin (Sigma-Aldrich), 100 µg/
mL streptomycin (Sigma-Aldrich) and 2.5 µg/mL 
fungizone (Sigma-Aldrich). Cell cultures were in-
cubated at 37°C in a humidified atmosphere of 5% 
CO2.  After 24 h of incubation, cell viability was 
evaluated through the 3-(4,5-dimetilazol-2-il)-2,5-
difeniltetrazolium bromida (MTT) reduction assay.
 Treatments were administered to 4 groups as 
follows: group 1, carbonated hydroxyapatite and 5% 
propolis (CHA+Prop.5%); group 2, carbonated hy-
droxyapatite and  7.5%  propolis  (CHA+Prop.7.5%); 
group 3, carbonated hydroxyapatite and 10% propo-
lis (CHA+Prop.10%); and carbonated hydroxyapa-
tite unembedded with propolis as the control group.
 Cells were cultured in 96-well microplates 
as treatment subjects. Three of the wells were used 
as cell controls. Those wells were only filled with 
fibroblast cells in DMEM without any treatment. 
Another three wells were used as media controls, 
with no fibroblast cells or treatment.
 The MTT assay was carried out by adding 
100 µL MTT solution at a concentration of 0.5 mg/
mL on the cultured cells. Sodium dodecyl sulfate 
solution 10% in 0.01 NHCL was added as the stop 
solution after 4 h. During 4 h, cells were incubated 
in 5% CO2 and 370C. Absorbance readings were 
taken using an ELISA reader at a wavelength of 
595 nm. The viable cell level was obtained by using 
the following formula (Shokrzadeh and Modanloo, 
2017): 
((Treatment absorbance–Media Control Absor-
bance)) / ((Cell control absorbance-Media Control 
Absorbance))  x 100%
Figure 2. Carbonated hydroxyapatite was embedded in 1.5 mL propolis.  From left 5% propolis, 7.5% propo-
lis, 10% propolis and control.
Figure 3. Cells were cultured in 96-well microplates as treatment subjects.
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Statistical analyses
 The percentage of viable cell level were 
analyzed by using parametric one-way ANOVA at 
the 95% level of significance, followed by the least 
significant difference (LSD) post hoc test.
RESULTS
 The Kolmogorov-Smirnov normality test 
showed that the data were normally distributed 
with p˃0.05. One-way ANOVA revealed a signifi-
cant  difference of variance between tested groups 
(p<0.05).  The data analysis then continued with the 
LSD post hoc test. Figure 1 shows that the mean 
percent cell viability of group 1 was the smallest 
of all 3 groups, namely 98.54%, while group 3 
showed the highest cell viability, and group 1 was 
the  lowest. The control group without the addition 
of   propolis showed 96.57% cell viability. 
DISCUSSION
 Carbonated hydroxyapatite is the result 
of substitution of carbonate ions with a phosphate 
group from hydroxyapatite. Calcium phosphate 
composite materials are needed to repair or re-
place damaged bones. Carbonated hydroxyapatite 
has high biocompatibility, bioactivity, and osteo-
conductive characteristics (Surbakti, et al., 2017). 
Osteoconduction is a physical effect by which the 
matrix of the graft forms a scaffold on which cells 
in the recipient site are able to form new bone (Su-
kumar and Drizhal, 2008).
 Propolis  contains  active ingredients such 
as  flavonoids and caffeic  acid  phenethyl ester 
(CAPE) (Darmadi  and  Mustamsir, 2016). Fla-
vonoids  are capable of  regulating  cell  function 
by stimulating the production of TGF-β, which may 
increase chemotaxis and  proliferation of fibroblasts 
in  the wound  area. The more fibroblasts  at  the 
injured  area,  the   synthesis  of   collagen   imme-
diately started so as to accelerate the wound-healing 
process (Suryono, et al., 2017). Propolis also con-
tains iron and zinc, which are important in collagen 
synthesis (Marcucci, 1995).
 The  results  of   this study   showed   that 
the incorporation   of  propolis   to   carbonated 
hydroxyapatite  increased fibroblast growth. These 
results are in accordance with research conducted 
by Silva, et al. (2017), which found that propolis 
had several advantageous effects, such as antibac-
terial, anti-inflammatory, immunomodulatory and 
antioxidant.
Figure 4. Mean values of cell growth in all groups.
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 Post hoc analysis found that the concen-
tration of propolis into carbonated hydroxyapatite 
determines the growth rate of fibroblast cells, and 
a propolis concentration of 10% gives the highest 
growth rate. These results are in accordance with 
previous studies by Suryono, et al. (2017), which 
demonstrated that 10% propolis can reduce the num-
ber of polymorphonuclear cells, stimulate fibroblast 
growth, and form new vascular tissue. Moreover, 
Özan, et al. (2007)   showed  that 10%  propolis 
was more  effective  at  maintaining  periodontal 
fibroblasts compared with Hank’s balanced salt 
solution and milk for up to 24 h. According to the 
research of Abdellatif, et al. (2014) propolis used as 
an orthotopic autograph coating material has a role 
as osteoinductive and that role cannot be achieved 
perfectly without the strength of osteoconductive 
autograph material.
 Fibroblasts are one of the most abundant 
cell types in connective tissues. These cells are 
responsible for tissue homeostasis under normal 
physiological conditions. When tissues are injured, 
fibroblasts become activated and differentiate into 
myofibroblasts, which generate large contractions 
and actively produce extracellular matrix (ECM) 
proteins to facilitate wound closure (Li and Wang, 
2011).
 In this study, 10 mg of  carbonated   hy-
droxyapatite was embedded in various concentra-
tions of propolis solution for 24 h. Carbonated hy-
droxyapatite is a highly biocompatible material that 
has osteoconductive properties and acts as a drug 
delivery system. Incorporating propolis into this 
bone graft material was expected to enhance its ca-
pacity for tissue repair (Mai, et al., 2008). Grenho, 
et al. (2015) reported that  embedding nanohy-
droxyapatite in propolis solution for 24 h did not 
show any toxic effects toward fibroblast cells. The 
cell growth test carried out in this study proved 
that carbonated hydroxyapatite with  incorporated 
propolis was not toxic, and could even stimulate the 
growth of fibroblast cells significantly. 
CONCLUSION
 The best concentration of propolis incorpo-
rated with carbonated hydroxyapatite which could 
stimulate proliferation of fibroblast cells line was 
found in 10%. 
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